This brand name is authorized in Brazil, Canada, Cyprus, Ecuador, Spain, France, Hong Kong, Ireland, Japan, Mexico, Nigeria, Netherlands, New Zealand, Poland, United Kingdom, United States, South Africa
The drug DIPRIVAN contains one active pharmaceutical ingredient (API):
1
Propofol
UNII YI7VU623SF - PROPOFOL
|
Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
DIPRIVAN Emulsion for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N01AX10 | Propofol | N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 505618040043417, 505618040043517, 505618040043617, 505618040043717, 505618040043817, 505618040043917 |
Country: CA | Health Products and Food Branch | Identifier(s): 02018950 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 25.364-10-03, 28011-06-09 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58785, 60744 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60616445, 62010414 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 43550, 47639, 47817 |
Country: HK | Department of Health Drug Office | Identifier(s): 27322 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1119402A1022, 1119402A2029, 1119402A3033, 1119402G1025, 1119402G2021 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 311M87 |
Country: NG | Registered Drug Product Database | Identifier(s): A4-6963 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 44652, 44660 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 3438, 8798 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100019367 |
Country: US | FDA, National Drug Code | Identifier(s): 63323-269, 65219-800 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 31/2.1/0375, 31/2.1/0376, 36/2.1/0084, 36/2.1/0085, 36/2.1/0086, T/2.1/226, X/2.1/30, X/2.1/31 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.